See the latest research that is likely to affect clinical practice for all dermatologists during four two-hour sessions presented Saturday and Sunday. The sessions will highlight clinical trials, procedural dermatology, basic science, cutaneous oncology, pathology, and pediatrics.
“These sessions are closely aligned to the AAD research agenda. The goal of sessions made up exclusively of late-breaking abstracts is to have researchers within the dermatology community submit their latest and greatest work and have it selected for open presentation at the meeting,” said Hensin Tsao, MD, PhD, director of the sessions.
All four sessions will feature 10-minute presentations, each followed by two minutes for a short discussion and a transition to the next presentation. Each of these presentations was chosen from more than 100 submitted abstracts. Speakers are encouraged to be available outside the room after their presentations to answer questions from attendees.
“All of these abstracts are embargoed until after the sessions, so I encourage everyone to come for the big reveal,” said Dr. Tsao, clinical director of the Massachusetts General Hospital Melanoma and Pigmented Lesion Center, and director of the MGH Melanoma Genetics Program. “It will move at a fast pace. Presenters will have to contextualize what their research is, present the studies, and deliver a take-home message.
“It will be exciting to see lots of new data from different areas, and all aspects of dermatology will be covered. With research going on in any area you could potentially be interested in, there will be something for everyone in these sessions.”
Attendees should not be scared off by thoughts of basic science research focusing on genetics or mouse studies, Dr. Tsao said.
“Every abstract selected has very obvious clinical relevance to practice,” he said. “Whether the topic is epidemiology research, trials, or basic science, each presentation will have take-home messages that should be relevant to everyone. If you attend the sessions, you will understand.”
According to Dr. Tsao, the sessions are part of the AAD’s increasing focus on highlighting the latest dermatology research at the Annual Meeting by covering topics from clinical trials to new agents to treatments for conditions, such as psoriasis and atopic dermatitis.
“These forums will showcase interesting new studies that speak to the way we will be practicing in one year or three years or five years,” he said. “People are excited to hear new things and the late-breaking abstracts will be an exciting component of the Annual Meeting. What a great forum for researchers making the big reveal of the first presentation of evidence at the world’s largest dermatology meeting.”